Loading…
Trisenox induces cytotoxicity through phosphorylation of mitogen‐activated protein kinase molecules in acute leukemia cells
Trisenox (TX) has been used successfully for the treatment of acute promyelocytic leukemia (APL) patients. TX‐induced cytotoxicity in APL cells remains poorly understood. In this study, we investigated the molecular mechanism of TX cytotoxicity using APL cell lines. We assessed TX toxicity by quanti...
Saved in:
Published in: | Journal of biochemical and molecular toxicology 2018-10, Vol.32 (10), p.e22207-N/A |
---|---|
Main Authors: | , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Trisenox (TX) has been used successfully for the treatment of acute promyelocytic leukemia (APL) patients. TX‐induced cytotoxicity in APL cells remains poorly understood. In this study, we investigated the molecular mechanism of TX cytotoxicity using APL cell lines. We assessed TX toxicity by quantitatively measuring lactate dehydrogenase levels. Inhibition of cell cycle progression was assessed by confocal microscopy of Ki‐67 expression. Apoptosis was evaluated by Western blot analysis of apoptotic proteins expression, immunocytochemistry, and confocal imaging of annexin V and propidium iodide. Mitogen‐activated protein kinase (MAPK) signaling cascade was analyzed by Western blot analysis and inhibitor‐based experiments with APL cells. We found that TX‐induced cytotoxicity inhibited APL cell cycle progression. TX also induced significant (P |
---|---|
ISSN: | 1095-6670 1099-0461 |
DOI: | 10.1002/jbt.22207 |